Alta Berkeley is a private equity general partner firm headquartered in London, United Kingdom and has other offices in Switzerland.
Aerie Pharmaceuticals' VC backers all plan to drop their stakes to below 20% through the eye disease treatment company's upcoming IPO.
VC-backed Aerie Pharmaceuticals, a developer of drugs for glaucoma patients, priced its IPO of 5.25m shares at between $12 and $14 each.
Read more news concerning Alta Berkeley
A sampling of Alta Berkeley portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?